This conjugate could use for subcutaneous hepatocellular carcinoma imaging in vivo, indicating that it might be a potential agent in glypican-3 positive tumor imaging for diagnosing hepatocellular carcinoma. This evidence concerns the gene GPC3 and neoplasm.